isocarboxazid has been researched along with Dizzyness in 3 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Isocarboxazid appears to be an underutilized and potentially valuable agent for the treatment of depressed patients." | 2.65 | Side effects of isocarboxazid. ( Zisook, S, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giller, E | 1 |
| Bialos, D | 1 |
| Harkness, L | 1 |
| Riddle, M | 1 |
| Zisook, S | 1 |
| Davidson, J | 1 |
| Turnbull, C | 1 |
2 trials available for isocarboxazid and Dizzyness
| Article | Year |
|---|---|
Assessing treatment response to the monoamine oxidase inhibitor isocarboxazid.
Topics: Ambulatory Care; Blood Platelets; Clinical Trials as Topic; Depressive Disorder; Dizziness; Double-B | 1984 |
Side effects of isocarboxazid.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Pressure; Clinical Trials as Topic; | 1984 |
1 other study available for isocarboxazid and Dizzyness
| Article | Year |
|---|---|
The importance of dose in isocarboxazid therapy.
Topics: Anxiety Disorders; Blood Platelets; Body Weight; Depressive Disorder; Dizziness; Dose-Response Relat | 1984 |